FI
HARP

Fosun International’s Harpoon Therapeutics, Inc. Common Stock HARP Stock Holding History

Fosun International’s Portfolio HARP Stock Details HARP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-19,048
Closed -$2.21M – 224
2020
Q1 		$2.21M Hold
19,048
– – 0.21% 52
2019
Q4 		$2.82M Sell
19,048
-13,292
-41% -$2.02M 0.23% 51
2019
Q3 		$4.42M Hold
32,340
– – 0.49% 28
2019
Q2 		$4.21M Hold
32,340
– – 0.28% 55
2019
Q1 		$3.06M Buy
+32,340
New +$4.25M 0.19% 71

Other funds holding HARP

MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fosun International's HARP Position: Q2 2020 in Review

Fosun International sold out of Harpoon Therapeutics, Inc. Common Stock (HARP) in Q2 2020, closing a stake of 19,048 shares — an estimated $2.21M sold.

Fosun International first reported a position in HARP in Q1 2019 and held it in 5 quarters. The position peaked at $4.42M in Q3 2019. 69 funds tracked by Wall St. Rank hold HARP as of Q2 2020.

  • Fosun International reported no remaining Harpoon Therapeutics, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
  • Fosun International sold 19,048 Harpoon Therapeutics, Inc. Common Stock shares in Q2 2020, an estimated $2.21M.
  • Fosun International first reported a position in Harpoon Therapeutics, Inc. Common Stock in Q1 2019 and held it in 5 quarters.
  • Fosun International's Harpoon Therapeutics, Inc. Common Stock position peaked at $4.42M in Q3 2019.
  • 69 funds tracked by Wall St. Rank held Harpoon Therapeutics, Inc. Common Stock as of Q2 2020.

Based on Fosun International's 13F filing for Q2 2020, filed 12 Aug 2020.